Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (311-320 of 574) with videos related to

Pageof 58
Sort By:
JTO Clinical and Research Reports|April 17, 2025
Myasthenia Gravis in Patients Treated With Immune Checkpoint InhibitorsAbdulrahman Alghabban, Lucy Corke, Hans Katzberg, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 23, 2022
Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck CancerChristopher W Noel, Katrina Hueniken, David Forner, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 11, 2023
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinomaUlf Zeuge, Aline F Fares, Joelle Soriano, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|October 27, 2016
Cancer Patients? Willingness to Routinely Complete the EQ-5D Instrument at Clinic VisitsHiten Naik, Xin Qiu, M Catherine Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosisDavid W Cescon, Penelope A Bradbury, Kofi Asomaning, et al.
Pharmacogenetics and Genomics|July 22, 2009
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomesPenelope A Bradbury, Matthew H Kulke, Rebecca S Heist, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)Catherine Labbé, Michael Cabanero, Grzegorz J Korpanty, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancerSabine Schmid, Miguel Garcia, Sierra Cheng, et al.
Clinical Trials (London, England)|January 31, 2015
Cancer patients' acceptability of incorporating an epidemiology questionnaire within a clinical trialSinead Cuffe, Henrique Hon, Kimberly Tobros, et al.
Plos One|October 31, 2019
Correction: Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinomaJennifer Teichman, Lorin Dodbiba, Henry Thai, et al.
Pageof 58

Showing results (311-320 of 574) with videos related to

Sort By:
Pageof 58
JTO Clinical and Research Reports|April 17, 2025
Myasthenia Gravis in Patients Treated With Immune Checkpoint InhibitorsAbdulrahman Alghabban, Lucy Corke, Hans Katzberg, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 23, 2022
Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck CancerChristopher W Noel, Katrina Hueniken, David Forner, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 11, 2023
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinomaUlf Zeuge, Aline F Fares, Joelle Soriano, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|October 27, 2016
Cancer Patients? Willingness to Routinely Complete the EQ-5D Instrument at Clinic VisitsHiten Naik, Xin Qiu, M Catherine Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosisDavid W Cescon, Penelope A Bradbury, Kofi Asomaning, et al.
Pharmacogenetics and Genomics|July 22, 2009
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomesPenelope A Bradbury, Matthew H Kulke, Rebecca S Heist, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)Catherine Labbé, Michael Cabanero, Grzegorz J Korpanty, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2022
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancerSabine Schmid, Miguel Garcia, Sierra Cheng, et al.
Clinical Trials (London, England)|January 31, 2015
Cancer patients' acceptability of incorporating an epidemiology questionnaire within a clinical trialSinead Cuffe, Henrique Hon, Kimberly Tobros, et al.
Plos One|October 31, 2019
Correction: Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinomaJennifer Teichman, Lorin Dodbiba, Henry Thai, et al.
Pageof 58